Best poster presentation

​

• Received during the 3rd Annual Meeting of the European Partnership for Alternative Approaches to Animal Testing (03/11/2008, Brussels-Belgium) for the poster “Establishment of an in vitro model of liver cell death” (Mathieu Vinken).

• Received during the 5th Annual carcinoGENOMICS Consortium Meeting (08-10/11/2010, Arona-Italy) for the poster “Epigenetically-stabilized primary hepatocyte cultures: a sensitive in vitro tool for hepatocarcinogenicity screening” (Tatyana Doktorova).

• Received during the International Gap Junction Conference (28/03-02/04/2015, Valparaiso-Chile) for the poster “The role of connexin43 hemichannels in limbic seizures” (Laura Walrave).

• Received during the XXIV Semana Científica Benjamin Eurico Malucceli (14-16/10/2015, São Paulo-Brazil) for the poster “Connexin32 signaling attenuates liver damage, liver steatosis and lipid peroxidation in a mouse model of non-alcoholic fatty liver disease” (Joost Willebrords).

• Received during the 21st Conference of the European Society for Toxicology In Vitro (21-25/11/2022, Sitges-Spain) for the presentation “Connexin-based channel activity is not specifically altered by hepatocarcinogenic chemicals” (Kaat Leroy).

• Received during the 21st Conference of the European Society for Toxicology In Vitro (21-25/11/2022, Sitges-Spain) for the presentation “Applying machine learning approaches to identify key genes associated with drug-induced cholestatic liver injury” (Jian Jiang).

• Received during the 3rd ASPIS Open Symposium (14-15/09/2023, Ljubljana-Slovenia) for the presentation “An updated adverse outcome pathway network for chemical-induced liver steatosis” (Anouk Verhoeven).

 

   

Best paper

​

• Received from the Universidade de São Paulo-Brazil (2015) for the paper by Vinken M., Maes M., Oliveira A.G., Cogliati B., Marques P.E., Menezes G.B., Zaidan Dagli M.L., Vanhaecke T., Rogiers V. (2014) Primary hepatocytes and their cultures in liver apoptosis research. Archives of Toxicology 88: 199-212 (Mathieu Vinken).

• Received from the Universidade de São Paulo-Brazil (2016) for the paper by Willebrords J., Veloso Alves Pereira I., Maes M., Crespo Yanguas S., Colle I., Van Den Bossche B., Da silva T.C., Oliveira C.P., Andraus W., Alves V.A., Cogliati B., Vinken M. (2015) Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research. Progress in Lipid Research 59: 106-125 (Joost Willebrords).

 

Research

​

• Dr. Karel-Lodewijk Verleysen Award of the Royal Academy of Medicine (Belgium, 2014) for the research “Connexin and pannexin hemichannels as biomarkers and drug targets in liver disease” (Mathieu Vinken).

• Galen Award for Pharmacology (Belgium, 2018) for the research “Cellular communication as a novel pharmacological target for the treatment of liver disease” (Mathieu Vinken).